Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...
Policymakers should focus on both obesity prevention and better access to treatment for those already living with obesity.
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results